Schedule and Publications

  • Home
  • Program
  • Schedule and Publications

Schedule and Publications

This page contains the list of tentatively accepted Scientific Sessions for the 2027 SOT Annual Meeting and ToxExpo. The final schedule of Scientific Sessions will be available in October 2026.

Scientific Sessions (Formerly Symposia, Workshops, and Roundtables)

Session names followed by  IAT  indicates that the session has been designated as an “Innovations in Applied Toxicology Session.” Session names followed by   ITS  indicates that the session has been designated as an “Innovations in Toxicological Sciences Session.”

  • Advancing Developmental Immunotoxicity Testing: Defining Mechanistic Benchmarks and Human-Relevant Frameworks for Risk Assessment
  • Advancing Medical Device Safety with Human-Relevant New Approach Methodologies
  • Advancing Next-Generation Risk Assessment Through Bayesian Uncertainty Characterization
  • AI Applications in Chemical Risk Assessment and Safety Science: Toward Predictive, Scalable, and Reduced Animal Testing Approaches
  • Antibody-Drug Conjugate–Associated Ocular Toxicity: Mechanistic and Clinical Insights That Guide Toxicological Assessments
  • Bridging Internal and External Exposure: Leveraging Human Biomonitoring Data Through Physiologically Based Kinetic Modeling Toward Next-Generation Risk Assessment  IAT 
  • Cancer Risk: It’s Not a Straight Line
  • Clearing the Canopy: Advancing Predictive Confidence in Respiratory In Vitro NAMs Through Model Characterization
  • Common Pathways, Divergent Outcomes: Decoding Complexity in Chemical Carcinogenesis
  • Common Sources of Error in Forensic Toxicology: Lessons from Casework and Laboratory Practice  IAT 
  • Comparative Approaches to Safety Evaluation of Cosmetics: Toxicological Paradigms, Risk Assessment Frameworks, and Regulatory Decision-Making
  • Complementary In Vitro and In Vivo Approaches to Address Emerging Inhaled Pollutants: E-cigarette Aerosols, Microplastics, and Air Pollution
  • Cross-Species Prediction of Chemical Effects Across Evolutionary and Biological Scales
  • Data-Driven Computational Approaches to Complex Chemical Mixtures
  • Defining the Chemical Universe for Understanding Chemical Safety
  • Effects of Parental Exposure to Environmental Chemicals on the Development and Health of the Offspring
  • Emerging Toxicology of Illicit Opioids: From Overdose Pathophysiology to Organ Injury and Medical Countermeasures  ITS 
  • Environmental Health Knowledgebases and Data Repositories  ITS 
  • Environmental Metal Mixtures and Early Life Kidney Health: A NAMs-to-TAMs Framework for Informing Human Health Risk
  • Environmental Toxicology in the Era of Big Data: Using the CHAMACOS Cohort as a Model for Exposure Science and Advancing Risk Assessment  IAT 
  • Exposome-Informed Approaches for Advancing Mechanistic Toxicology and Risk Assessment
  • Extracellular Vesicles as Mechanistic Mediators of Respiratory Toxicity
  • Food Safety in the Real World: Why Cumulative Risk Matters
  • From Animals to Alternatives: Integrating and Validating MPS for Chemical and Biological Defense
  • From Exposure to Outcome: Mechanistic Pathways in Autoimmune Diseases
  • From Innovation to Integration: Implementing NAMs for Human Risk Assessment in Drug Discovery Toxicology
  • Harmonizing Weight of Evidence Assessments: The PRAGMATIC Framework for Global Chemical Safety Evaluation
  • How (Un-)Certain Is (Un-)Safe? Quantifying Uncertainty in the Era of NAMs and NGRA
  • How Do Chemical Exposures Affect the Tumor-Immune Microenvironment?
  • Immunogenicity Crystal Ball: Integrating In Silico and Experimental Strategies for Predictive Immunogenicity Risk Assessment
  • Integrating Exposomics into Neurotoxicity Studies to Better Understand Mixtures and Cumulative Risk
  • Integrating Intestinal Biology into NAMs Across Sectors
  • Integrating New Data Streams into the Developmental Neurotoxicity In Vitro Battery
  • Kratom Craze: Science, Safety, and Regulation in the Age of Novel Products
  • Make New NAMs, Keep the Old: Advancing Physiological Relevance of Existing and Next-Generation NAMs Through Integrated Metabolism
  • Metals on the Menu in the Exposome Era: How Dietary Metals Rewire Systemic Health
  • Micro- and Nanoplastics in the Brain: From Exposure to Neural Function
  • Molecular Biomarkers for Early Assessment of Cancer Risk
  • Not So Black and White: Multimodal Insights into White Matter Toxicity Across the Lifespan
  • Occupational Exposure to 3D Printing Emissions and Potential Health Impacts
  • Oxidative Stress as a Translational Key Event in Pesticide Toxicity: From Adverse Outcome Pathways to One Health Risk Assessment
  • Particles, Exposure, and Nephrotoxicity: Emerging Insights into Inhalation-Induced Kidney Damage
  • QIVIVE: A NAMs-Powered Framework for Exposure and Risk Assessment
  • Quantifying AOPs for Predictive Dev Tox: DARTable Genome and PBPK-Driven NAMs for Regulatory De-risking
  • Quantitative In Vitro to In Vivo Extrapolation for Consideration in Chemical Safety Decisions: Bridging Platforms, Endpoints, and Regulatory Needs
  • Raising the Bar: Modern Intake Assessments and the New Regulatory Landscape for Food Ingredient Safety
  • Rapid Toxicity Reference Values for Applied Regulatory Needs  IAT 
  • Reimagining Reproductive and Developmental Toxicology: Stem Cell–Derived Organoid-Based New Approach Methodologies Across Windows of Susceptibility  ITS 
  • Revealing the Nanoplastics Dilemma: Biodistribution, Biological Effects, and Toxicological Implications for the Nervous System
  • Seeing the Side Effects: Ocular Toxicity Associated with Systemic Therapeutics
  • Silica, Asbestos, Metals, and Dust: Mechanisms of Lung Injury, Impaired Repair, and Disease
  • The Rewritable Liver: Environmental Exposures and the Erosion of Sexual Dimorphism
  • The Use of NAMs in Food Safety: State of Practice and Opportunities for New Science
  • The Vagina Monologues: Expanding Reproductive Toxicology to the Vaginal Interface
  • Toxicology and Advanced Nanoscience in Lipid Nanoparticle mRNA-Based Therapies
  • Transcriptomics, Beyond Concept to Utilization: Practical Considerations and Successes for Regulatory Applications
  • Transforming Drug Discovery Using Agentic AI for Target Knowledge Reviews and Weight of Evidence Decision-Making  IAT 
  • Two Species or Not Two Species? New Data to Re-evaluate Toxicology Testing Strategies Across the Sectors

Informational Sessions

  • Clearing the Air: Challenges and Strategies for Analyzing Breathing Gas Pathway Devices
  • Fixing the Implementation Gap: Best Practices for Validating a Test Method to Inform Regulatory Decision-Making
  • From Thresholds to Frameworks: The Evolution of TTC for Modern Safety Assessment
  • Large-Scale Lithium-Ion Battery Fire Events: Chemical, Elemental, and Exposure Hazards
  • Methods and Strategies to Advance the Safety and Regulatory Compliance of Consumer and Non-consumer Products Sold in the United States Using Hazard-Based or Risk-Based Approaches
  • Multiple Strategies to Leverage Existing Work to Understand Toxicant Contributors to Autism: Lessons from the Autism Data Science Initiative
  • Navigating PFAS in Medical Device Safety: A Cross-Disciplinary Scientific Evaluation of Materials, Biological Safety, Product Stewardship, and Emerging Toxicological Approaches
  • Next-Generation Read-Across: Improved Understanding of Relevant Uncertainties
  • Occupational Exposure Limits: Translating Hazard Assessment Data on Reproductive and Developmental Toxicity to the Workplace
  • Signals, Soundbites, and Science: Expanding the Landscape of Toxicology Communication
  • Sniffing Out the Danger: Safety Assessments for Companion Animals
  • Sustainable Chemistry Across Sectors: How Toxicology Informs Decisions in Electronics, Consumer Products, and Municipal Government
  • When Other Species Bail on You, Minipig to the Rescue: An Evidence-Based Alternative for DART and Juvenile Toxicology Programs

Regional Interest Session

  • Federal and State Toxicologists Dancing the Texas Two-Step: Protecting the Environment and Public Health

Engagement Sessions

  • Challenging the Status Quo: The History, Science, and Psychology Behind NAM Validation
  • Guardians of Public Health Volume 2: Emergency Response Case Studies
  • Resilience and Reinvention: Navigating Career Transitions in Toxicology
  • Rethinking DART Testing: Advancing Dev Tox NAMs Through Stakeholder Dialogue
  • What’s on Your Plate? Unintentional Food Contaminants and Nutritional Strategies for Health
  • When AI Contradicts Biology: How Should Toxicologists Respond?

Education-Career Advancement Sessions

  • Decision-Making Across the Drug Development Continuum: How Does It Align with Your Career Path?
  • The Many Paths to a Career in Computational Toxicology

Continuing Education Courses

Fifteen Continuing Education courses will be offered during the 2027 SOT Annual Meeting and ToxExpo for an add-on fee. For details on these courses, including information on how to register, visit the “Continuing Education” web page.